Report Detail

Medical Devices & Consumables Global Drug-Coated Balloons Market Outlook 2021

  • RnM4253484
  • |
  • 17 November, 2020
  • |
  • Global
  • |
  • 134 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Drug-Coated Balloons Market Overview

  • 1.1 Product Overview and Scope of Drug-Coated Balloons
  • 1.2 Drug-Coated Balloons Segment by Type
    • 1.2.1 Global Drug-Coated Balloons Production Growth Rate Comparison by Type 2020 VS 2026
    • 1.2.2 DCB for Peripheral Artery Disease
    • 1.2.3 DCB for Coronary Artery Disease
    • 1.2.4 DCB for Other Indications
  • 1.3 Drug-Coated Balloons Segment by Application
    • 1.3.1 Drug-Coated Balloons Consumption Comparison by Application: 2020 VS 2026
    • 1.3.2 Hospitals
    • 1.3.3 Cardiac Catheterization Labs
    • 1.3.4 ASCs
  • 1.4 Global Drug-Coated Balloons Market by Region
    • 1.4.1 Global Drug-Coated Balloons Market Size Estimates and Forecasts by Region: 2020 VS 2026
    • 1.4.2 North America Estimates and Forecasts (2015-2026)
    • 1.4.3 Europe Estimates and Forecasts (2015-2026)
    • 1.4.4 China Estimates and Forecasts (2015-2026)
    • 1.4.5 Japan Estimates and Forecasts (2015-2026)
  • 1.5 Global Drug-Coated Balloons Growth Prospects
    • 1.5.1 Global Drug-Coated Balloons Revenue Estimates and Forecasts (2015-2026)
    • 1.5.2 Global Drug-Coated Balloons Production Capacity Estimates and Forecasts (2015-2026)
    • 1.5.3 Global Drug-Coated Balloons Production Estimates and Forecasts (2015-2026)
  • 1.6 Drug-Coated Balloons Industry
  • 1.7 Drug-Coated Balloons Market Trends

2 Market Competition by Manufacturers

  • 2.1 Global Drug-Coated Balloons Production Capacity Market Share by Manufacturers (2015-2020)
  • 2.2 Global Drug-Coated Balloons Revenue Share by Manufacturers (2015-2020)
  • 2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Drug-Coated Balloons Average Price by Manufacturers (2015-2020)
  • 2.5 Manufacturers Drug-Coated Balloons Production Sites, Area Served, Product Types
  • 2.6 Drug-Coated Balloons Market Competitive Situation and Trends
    • 2.6.1 Drug-Coated Balloons Market Concentration Rate
    • 2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Drug-Coated Balloons Market Share by Regions (2015-2020)
  • 3.2 Global Drug-Coated Balloons Revenue Market Share by Regions (2015-2020)
  • 3.3 Global Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.4 North America Drug-Coated Balloons Production
    • 3.4.1 North America Drug-Coated Balloons Production Growth Rate (2015-2020)
    • 3.4.2 North America Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.5 Europe Drug-Coated Balloons Production
    • 3.5.1 Europe Drug-Coated Balloons Production Growth Rate (2015-2020)
    • 3.5.2 Europe Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.6 China Drug-Coated Balloons Production
    • 3.6.1 China Drug-Coated Balloons Production Growth Rate (2015-2020)
    • 3.6.2 China Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.7 Japan Drug-Coated Balloons Production
    • 3.7.1 Japan Drug-Coated Balloons Production Growth Rate (2015-2020)
    • 3.7.2 Japan Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Drug-Coated Balloons Consumption by Regions

  • 4.1 Global Drug-Coated Balloons Consumption by Regions
    • 4.1.1 Global Drug-Coated Balloons Consumption by Region
    • 4.1.2 Global Drug-Coated Balloons Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Drug-Coated Balloons Consumption by Countries
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Drug-Coated Balloons Consumption by Countries
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Drug-Coated Balloons Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Drug-Coated Balloons Consumption by Countries
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Drug-Coated Balloons Production, Revenue, Price Trend by Type

  • 5.1 Global Drug-Coated Balloons Production Market Share by Type (2015-2020)
  • 5.2 Global Drug-Coated Balloons Revenue Market Share by Type (2015-2020)
  • 5.3 Global Drug-Coated Balloons Price by Type (2015-2020)
  • 5.4 Global Drug-Coated Balloons Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Drug-Coated Balloons Market Analysis by Application

  • 6.1 Global Drug-Coated Balloons Consumption Market Share by Application (2015-2020)
  • 6.2 Global Drug-Coated Balloons Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Drug-Coated Balloons Business

  • 7.1 Medtronic
    • 7.1.1 Medtronic Drug-Coated Balloons Production Sites and Area Served
    • 7.1.2 Medtronic Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.1.3 Medtronic Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.1.4 Medtronic Main Business and Markets Served
  • 7.2 BD
    • 7.2.1 BD Drug-Coated Balloons Production Sites and Area Served
    • 7.2.2 BD Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.2.3 BD Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.2.4 BD Main Business and Markets Served
  • 7.3 B. Braun Melsungen
    • 7.3.1 B. Braun Melsungen Drug-Coated Balloons Production Sites and Area Served
    • 7.3.2 B. Braun Melsungen Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.3.3 B. Braun Melsungen Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.3.4 B. Braun Melsungen Main Business and Markets Served
  • 7.4 Koninklijke Philips
    • 7.4.1 Koninklijke Philips Drug-Coated Balloons Production Sites and Area Served
    • 7.4.2 Koninklijke Philips Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.4.3 Koninklijke Philips Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.4.4 Koninklijke Philips Main Business and Markets Served
  • 7.5 Boston Scientific
    • 7.5.1 Boston Scientific Drug-Coated Balloons Production Sites and Area Served
    • 7.5.2 Boston Scientific Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.5.3 Boston Scientific Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.5.4 Boston Scientific Main Business and Markets Served
  • 7.6 Opto Circuits (India)
    • 7.6.1 Opto Circuits (India) Drug-Coated Balloons Production Sites and Area Served
    • 7.6.2 Opto Circuits (India) Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.6.3 Opto Circuits (India) Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.6.4 Opto Circuits (India) Main Business and Markets Served
  • 7.7 Acotec Scientific
    • 7.7.1 Acotec Scientific Drug-Coated Balloons Production Sites and Area Served
    • 7.7.2 Acotec Scientific Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.7.3 Acotec Scientific Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.7.4 Acotec Scientific Main Business and Markets Served
  • 7.8 AR Baltic Medical
    • 7.8.1 AR Baltic Medical Drug-Coated Balloons Production Sites and Area Served
    • 7.8.2 AR Baltic Medical Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.8.3 AR Baltic Medical Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.8.4 AR Baltic Medical Main Business and Markets Served
  • 7.9 Acrostak
    • 7.9.1 Acrostak Drug-Coated Balloons Production Sites and Area Served
    • 7.9.2 Acrostak Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.9.3 Acrostak Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.9.4 Acrostak Main Business and Markets Served
  • 7.10 Biosensors International Group
    • 7.10.1 Biosensors International Group Drug-Coated Balloons Production Sites and Area Served
    • 7.10.2 Biosensors International Group Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.10.3 Biosensors International Group Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.10.4 Biosensors International Group Main Business and Markets Served
  • 7.11 BioMed
    • 7.11.1 BioMed Drug-Coated Balloons Production Sites and Area Served
    • 7.11.2 BioMed Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.11.3 BioMed Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.11.4 BioMed Main Business and Markets Served
  • 7.12 Concept Medical
    • 7.12.1 Concept Medical Drug-Coated Balloons Production Sites and Area Served
    • 7.12.2 Concept Medical Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.12.3 Concept Medical Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.12.4 Concept Medical Main Business and Markets Served
  • 7.13 Cardionovum
    • 7.13.1 Cardionovum Drug-Coated Balloons Production Sites and Area Served
    • 7.13.2 Cardionovum Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.13.3 Cardionovum Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.13.4 Cardionovum Main Business and Markets Served
  • 7.14 Endocor
    • 7.14.1 Endocor Drug-Coated Balloons Production Sites and Area Served
    • 7.14.2 Endocor Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.14.3 Endocor Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.14.4 Endocor Main Business and Markets Served
  • 7.15 Hexacath Sverige
    • 7.15.1 Hexacath Sverige Drug-Coated Balloons Production Sites and Area Served
    • 7.15.2 Hexacath Sverige Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.15.3 Hexacath Sverige Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.15.4 Hexacath Sverige Main Business and Markets Served
  • 7.16 iVascular SLU
    • 7.16.1 iVascular SLU Drug-Coated Balloons Production Sites and Area Served
    • 7.16.2 iVascular SLU Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.16.3 iVascular SLU Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.16.4 iVascular SLU Main Business and Markets Served
  • 7.17 Minvasys
    • 7.17.1 Minvasys Drug-Coated Balloons Production Sites and Area Served
    • 7.17.2 Minvasys Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.17.3 Minvasys Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.17.4 Minvasys Main Business and Markets Served
  • 7.18 MedAlliance
    • 7.18.1 MedAlliance Drug-Coated Balloons Production Sites and Area Served
    • 7.18.2 MedAlliance Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.18.3 MedAlliance Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.18.4 MedAlliance Main Business and Markets Served
  • 7.19 QT Vascular
    • 7.19.1 QT Vascular Drug-Coated Balloons Production Sites and Area Served
    • 7.19.2 QT Vascular Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.19.3 QT Vascular Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.19.4 QT Vascular Main Business and Markets Served
  • 7.20 RD Global-Invamed
    • 7.20.1 RD Global-Invamed Drug-Coated Balloons Production Sites and Area Served
    • 7.20.2 RD Global-Invamed Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.20.3 RD Global-Invamed Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.20.4 RD Global-Invamed Main Business and Markets Served
  • 7.21 SurModics
    • 7.21.1 SurModics Drug-Coated Balloons Production Sites and Area Served
    • 7.21.2 SurModics Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.21.3 SurModics Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.21.4 SurModics Main Business and Markets Served
  • 7.22 Terumo
    • 7.22.1 Terumo Drug-Coated Balloons Production Sites and Area Served
    • 7.22.2 Terumo Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.22.3 Terumo Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.22.4 Terumo Main Business and Markets Served
  • 7.23 Wellinq
    • 7.23.1 Wellinq Drug-Coated Balloons Production Sites and Area Served
    • 7.23.2 Wellinq Drug-Coated Balloons Product Introduction, Application and Specification
    • 7.23.3 Wellinq Drug-Coated Balloons Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.23.4 Wellinq Main Business and Markets Served

8 Drug-Coated Balloons Manufacturing Cost Analysis

  • 8.1 Drug-Coated Balloons Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Drug-Coated Balloons
  • 8.4 Drug-Coated Balloons Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Drug-Coated Balloons Distributors List
  • 9.3 Drug-Coated Balloons Customers

10 Market Dynamics

  • 10.1 Market Trends
  • 10.2 Opportunities and Drivers
  • 10.3 Challenges
  • 10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Drug-Coated Balloons (2021-2026)
  • 11.2 Global Forecasted Revenue of Drug-Coated Balloons (2021-2026)
  • 11.3 Global Forecasted Price of Drug-Coated Balloons (2021-2026)
  • 11.4 Global Drug-Coated Balloons Production Forecast by Regions (2021-2026)
    • 11.4.1 North America Drug-Coated Balloons Production, Revenue Forecast (2021-2026)
    • 11.4.2 Europe Drug-Coated Balloons Production, Revenue Forecast (2021-2026)
    • 11.4.3 China Drug-Coated Balloons Production, Revenue Forecast (2021-2026)
    • 11.4.4 Japan Drug-Coated Balloons Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted and Consumption Demand Analysis of Drug-Coated Balloons
  • 12.2 North America Forecasted Consumption of Drug-Coated Balloons by Country
  • 12.3 Europe Market Forecasted Consumption of Drug-Coated Balloons by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Drug-Coated Balloons by Regions
  • 12.5 Latin America Forecasted Consumption of Drug-Coated Balloons

13 Forecast by Type and by Application (2021-2026)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
    • 13.1.1 Global Forecasted Production of Drug-Coated Balloons by Type (2021-2026)
    • 13.1.2 Global Forecasted Revenue of Drug-Coated Balloons by Type (2021-2026)
    • 13.1.3 Global Forecasted Price of Drug-Coated Balloons by Type (2021-2026)
  • 13.2 Global Forecasted Consumption of Drug-Coated Balloons by Application (2021-2026)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    DCB for Peripheral Artery Disease
    DCB for Coronary Artery Disease
    DCB for Other Indications

    Segment by Application
    Hospitals
    Cardiac Catheterization Labs
    ASCs

    Global Drug-Coated Balloons Market: Regional Analysis
    The report offers in-depth assessment of the growth and other aspects of the Drug-Coated Balloons market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
    The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.

    Global Drug-Coated Balloons Market: Competitive Landscape
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
    The major players in the market include Medtronic, BD, B. Braun Melsungen, Koninklijke Philips, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, BioMed, Concept Medical, Cardionovum, Endocor, Hexacath Sverige, iVascular SLU, Minvasys, MedAlliance, QT Vascular, RD Global-Invamed, etc.


    Summary:
    Get latest Market Research Reports on Drug-Coated Balloons. Industry analysis & Market Report on Drug-Coated Balloons is a syndicated market report, published as Global Drug-Coated Balloons Market Outlook 2021. It is complete Research Study and Industry Analysis of Drug-Coated Balloons market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,171.64
    3,257.45
    4,343.27
    2,436.97
    3,655.46
    4,873.94
    302,847.00
    454,270.50
    605,694.00
    214,292.31
    321,438.47
    428,584.62
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report